KLK3 and posterior cortical atrophy: In accordance with the guidelines from the European Association of Urology (EAU), PSMA PET/CT is recommended for evaluating the likelihood of PCa recurrence and distant metastasis in patients with PSA levels exceeding 0.2 ng/ml who are candidates for salvage therapy.